President-elect Donald Trump has named Robert F. Kennedy Jr. as his pick to lead the U.S. Department of Health and Human Services (HHS), where he will have the chance to advance major drug policy reforms he’s championed such as promoting access to psychedelics therapy and reshaping federal marijuana laws.

Kennedy followed a dizzying path to the Trump administration, entering the 2024 presidential election as a Democratic candidate before switching to independent as he lagged in the polls and then eventually endorsing the GOP nominee. Along that path, he stood out in part for his drug policy platform, which involved legalizing and taxing certain psychedelics in addition to cannabis.

If confirmed by the Senate or otherwise elevated to health and human services secretary via a recess appointment, Kennedy will be in a unique position of influence to follow up on those goals, commanding control of the nation’s health apparatus that oversees the Food and Drug Administration (FDA) and other critical agencies.

Read the full article at Marijuana Moment